BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16598774)

  • 1. Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation.
    Tsuruga E; Rao DS; Baatz JE; Reddy SV
    J Cell Biochem; 2006 Aug; 98(6):1681-8. PubMed ID: 16598774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.
    Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR
    J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells.
    Kajiya H; Ito M; Ohshima H; Kenmotsu S; Ries WL; Benjamin IJ; Reddy SV
    J Cell Biochem; 2006 Apr; 97(6):1362-9. PubMed ID: 16365894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.
    Sundaram K; Senn J; Reddy SV
    J Cell Biochem; 2013 Sep; 114(9):2032-8. PubMed ID: 23553658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
    Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF-2 stimulation of RANK ligand expression in Paget's disease of bone.
    Sundaram K; Senn J; Yuvaraj S; Rao DS; Reddy SV
    Mol Endocrinol; 2009 Sep; 23(9):1445-54. PubMed ID: 19556344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
    BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.
    Secchiero P; Melloni E; Corallini F; Beltrami AP; Alviano F; Milani D; D'Aurizio F; di Iasio MG; Cesselli D; Bagnara GP; Zauli G
    Stem Cells; 2008 Nov; 26(11):2955-63. PubMed ID: 18772312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
    Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic gene expression in Paget's disease: a possible role for Bcl-2.
    Brandwood CP; Hoyland JA; Hillarby MC; Berry JL; Davies M; Selby PL; Mee AP
    J Pathol; 2003 Nov; 201(3):504-12. PubMed ID: 14595764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
    Zhang Y; Shen X
    Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
    Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
    Mangham DC; Davie MW; Grimer RJ
    Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.